SEC Company Response from Propanc Biopharma, Inc. (PPCB) (CIK 0001517681) (PPCB) — Apr 14, 2016
Propanc Biopharma, Inc. (PPCB) (CIK 0001517681)
Date: April 14, 2016 · CIK: 0001517681 · Accession: 0001144204-16-094275
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-210400
Letter
Propanc Health Group Corporation
Level 2, 555 Riversdale Road
Camberwell, VIC, 3124 Australia
Tel. No.: +61 (0)3 9882 0780
April 14, 2016
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Propanc Health Group Corporation (the “Company)
Registration Statement on Form S-1
File No. 333-210400 (the “Registration Statement”)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 10:00 am on Monday, April 18, 2016, or as soon thereafter as is practicable.
The Company acknowledges that:
· should the Commission or the staff, acting pursuant to delegated authority, declares the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Propanc Health Group Corporation
Show Raw Text
CORRESP 1 filename1.htm Propanc Health Group Corporation Level 2, 555 Riversdale Road Camberwell, VIC, 3124 Australia Tel. No.: +61 (0)3 9882 0780 April 14, 2016 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Propanc Health Group Corporation (the “Company) Registration Statement on Form S-1 File No. 333-210400 (the “Registration Statement”) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 10:00 am on Monday, April 18, 2016, or as soon thereafter as is practicable. The Company acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declares the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, Propanc Health Group Corporation By: /s/ James Nathanielsz Name: James Nathanielsz Title: Chief Executive Officer